H1 Review: Deal volume steady in southern Europe; value drops
Despite political uncertainty and fear of an imminent downturn, private equity activity in southern Europe held up decently in the first half of 2019. Furthermore, market sentiment indicates that the upcoming pipeline still offers investors an attractive array of opportunities. Alessia Argentieri reports
More on Southern Europe
Riverside carves out HealthTech BioActives from Ferrer
Deal includes three manufacturing facilities located in Spain, which employ around 140 staff
Ergon Capital buys Palex Medical from Corpfin
GP deploys capital from Ergon Capital Partners IV fund, which closed on €580m in March 2019
One Equity Partners backs Nexion
GP intends to accelerate the company's organic growth and further boost its international expansion
Xenon acquires Koverlux from B4 Investimenti
GP buys the company from private equity house B4 Investimenti and founders Giuseppe and Luca Cerea
Latest News
Riverside carves out HealthTech BioActives from Ferrer
Deal includes three manufacturing facilities located in Spain, which employ around 140 staff
Capvis buys Tertianum Group
GP acquired the care home group from Swiss Prime Site and will be the company's sole shareholder
Iris Capital, Idinvest et al. inject $12.3m into Yubo
Iris, Idinvest and historical backers invest in the manager of the eponymous social media app
Mérieux Equity Partners backs Addmedica
GP uses its Mérieux Participations 3 fund, which held a first close on €200m in 2018